drugset / Trial / NCT06462118
A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects
RandomizedParallel-groupOpen-labelBasic science
Summary
The main objective is to study how astegolimab may behave in the body when injected subcutaneously into the abdomen, thigh, or upper arm in healthy participants.
Timeline
- Start
- 2024-06-17
- Primary completion
- 2024-10-22
- Completion
- 2024-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Astegolimab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.